They discovered that mRNA vaccines work like an alarm, putting the bodys immune system on high alert to recognize and attack cancer cells
The safety profile of semaglutide 2.4 mg in STEP 5 was consistent with that in other STEP program trials 6,7,9,16,23 , and with the GLP-1 receptor agonist class in general 28
Three Warning Letters in Six Months The March 2026 letter is the third FDA warning to Novo Nordisk in six months
Age-related changes in kidney and liver function may affect drug metabolism and clearance, potentially increasing the risk of adverse effects
Research has shown semaglutide exhibits potential in the management of non-alcoholic fatty liver disease (NAFLD)
The chart below outlines some of the major differences between whole blood vs